Covid-19 Countermeasures: Evidence for an Intent to Harm

Alexandra (Sasha) Latypova – Pandemic Strategies, Lessons and Consequences, 21st- 22nd January 2023 (Lakaruppropet/Rumble):

A bit of Sasha’s background:

I am an ex-pharmaceutical research and development (R&D) industry executive and entrepreneur. I spent 25 years working in the industry in various roles, countries and ultimately managing my own companies. I worked initially as an econometrics and management consultant, and later as clinical trials contractor for 60+ pharmas, large and small. My clients included Pfizer, Johnson & Johnson, Novartis, AstraZeneca, GSK, and many smaller biotechs. I worked with “channel partners” such as large contract research organizations (CROs) – Parexel, PPD, ICON, and others. I interacted with the FDA and other regulators on behalf of my clients, and as a member of Cardiovascular Safety Research Consortium on subjects related to assessments of cardiovascular safety of new drugs in clinical trials. Around that time, I met Robert Califf who is now the Commissioner of the FDA. He was my business competitor and was running rather poor quality cardiac safety trials for pharma at an academic lab at Duke University. (…)

Coming back to the present, I grew increasingly alarmed by the government’s nonsensical and counterproductive actions marketed as “fighting covid”, but the realization that something truly fraudulent was going on came to me around April 2020 when suppression of hydroxychloroquine and other early treatments became quite obvious. The HHS was pushing an outright lie about this well characterized and helpful medicine with a very long history of practical application, and since they are professionals, just like myself, I knew they were lying outright. They could not NOT know. I started looking into data for myself. You can view all my analyses since then in a series of narrated powerpoint presentations and interviews on my Bitchute page here.


Backup videos: